Neuexcell
State College, US · Founded 2016 · 1 known investors
NeuExcell Therapeutics is a clinical-stage gene therapy company developing treatments for neurodegenerative and neurological diseases such as glioma, Alzheimer's disease, and stroke. Its ATN (Astrocytes To Neurons) platform converts glial cells into functional neurons in vivo to repair damaged brain tissue.
Founders & leadership
Neuexcell was founded in 2016 by Gong Chen.
GC
Gong ChenCEO
JX
Jie XuSecretary
Investors · 1
Reported raises · per SEC filings
Form D private placements$850K disclosed across 1 round · 2016
▶$850KraisedMay 2016 · 3 investors · BiotechnologyRule 506(b)
▶$850KraisedMay 2016 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gong ChenExecutive Officer
- Jie XuExecutive Officer
- Amount sold
- $850K
- Minimum investment
- $50K
- First sale
- May 2016
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Neuexcell do?
- NeuExcell Therapeutics is a clinical-stage gene therapy company developing treatments for neurodegenerative and neurological diseases such as glioma, Alzheimer's disease, and stroke. Its ATN (Astrocytes To Neurons) platform converts glial cells into functional neurons in vivo to repair damaged brain tissue.
- Who founded Neuexcell?
- Neuexcell was founded by Gong Chen in 2016.
- Who are Neuexcell's investors?
- Neuexcell's investors include Foothill Ventures.
- How much funding has Neuexcell raised?
- Neuexcell has disclosed $850K raised across 1 round.
- Where is Neuexcell headquartered?
- Neuexcell is headquartered in State College, US.